SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-017973
Filing Date
2024-04-04
Accepted
2024-04-04 16:33:33
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A ny20016521x3_defa14a.htm DEFA14A 14125
2 ny20016521x3_nc01.jpg GRAPHIC 1215391
3 ny20016521x3_nc02.jpg GRAPHIC 1626524
  Complete submission text file 0001140361-24-017973.txt   3926391
Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37587 | Film No.: 24823563
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)